{
    "organizations": [],
    "uuid": "47776e7286710a18c39f8f661d3c52316606892d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sunesis-pharma-qtrly-loss-per-shar/brief-sunesis-pharma-qtrly-loss-per-share-0-21-idUSASB0C9K0",
    "ord_in_thread": 0,
    "title": "BRIEF-Sunesis Pharma Qtrly Loss Per Share $0.21",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Sunesis Pharmaceuticals Inc:\n* SUNESIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS\n* QTRLY LOSS PER SHARE $0.21 * Q4 EARNINGS PER SHARE VIEW $-0.29 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:24:00.000+02:00",
    "crawled": "2018-03-09T14:44:43.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "sunesis",
        "pharmaceutical",
        "inc",
        "sunesis",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "recent",
        "highlight",
        "qtrly",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}